SOURCE: Inforsense, Ltd.

February 25, 2008 09:00 ET

InforSense Launches Translational Research Solution

Erasmus Medical Center Benefits From Solution's Ability to Analyze and Integrate Large Clinical and Experimental Data Sets

ORLANDO, FL--(Marketwire - February 25, 2008) - HIMSS 2008 Annual Conference & Exhibition -- InforSense Ltd., the leading provider of embedded enterprise intelligence, today announced the InforSense Translational Research Solution. The new solution provides out-of-the-box tools and capabilities to integrate basic scientific research data and techniques with clinical research to improve disease understanding and patient care. World class healthcare institutions, such as Erasmus Medical Center, are using the InforSense solution in their translational research.

"The bioinformatics team at Erasmus MC is collaborating with our clinicians and researchers to develop ground-breaking translational research applications," said Peter van der Spek, Head of Erasmus Center for Bioinformatics. "We are actively working in the areas of gene expression, image analysis and Genome Wide Association Studies and needed a platform that enables us to bring these different technologies and data sources together with clinical patient data."

"We have selected the InforSense Translational Research Solution because it provides the integration capabilities we need with out-of-the-box analytical workflows and user interfaces for translational research," continued van der Spek. "In addition, the InforSense platform gives us the power and process flexibility to quickly develop our own best practice analysis workflows and deploy them, via a web interface, to our scientists."

"The InforSense Translational Research Solution aims to address a key bottleneck for innovation facing leading pharmaceutical, biotech and medical research organizations equally," said Keith Strier, Principal, Health Sciences & Government, at Deloitte Consulting LLP and national leader of its biomedical informatics practice. "By offering an information model that connects clinical with molecular data, InforSense offers a platform for more personalized and targeted medicine that is architected to serve the needs of both clinicians and researchers. InforSense is ahead of the curve."

"We have been working with many leading institutions to develop capabilities to enable translational research and we wanted to package this functionality together to support scientists working in this area," said Jonathan Sheldon, InforSense Chief Scientific Officer. "Our experience with clinical institutes and working with experimental data in the world's leading companies makes InforSense an ideal platform for translational research. Because this is such a new and evolving area, the analytical power and flexibility we provide is essential to develop and evolve new best practices."

About InforSense Translational Research Solution

The InforSense Translational Research Solution provides a powerful and flexible framework to integrate and analyze clinical, patient specimen and experimental data for translational research. The solution enables different user groups to integrate data and construct analysis workflows which can then be deployed to a wider scientific audience. This unified system is able to utilize any experimental technique to support the identification of biomarkers, including Genome Wide Association studies, gene expression, proteomics and image analysis. The ability to integrate these techniques together means that they can be easily analyzed and compared ensuring the best technique and approach is being used. Features include:

--  Easy integration of data sets - All clinical, patient sample and
    experimental data can be integrated into a consistent informatics platform
    improving decision making by incorporating all available data
--  Simple web interface - Study designers and scientists can query and
    analyze the data through simple web interfaces produced by expert
    developers and statisticians, removing bottlenecks in accessing the data
--  Flexible platform - Workflows can be quickly developed and evolved
    enabling best practices to be flexibly optimized rather than needing to re-
    implement systems with each iteration
--  Advanced and scalable analytics - Proven scalability of the InforSense
    platform allows large data sets to analyzed using a wide variety of pre-
    integrated tools such as R and SAS providing a future proof environment
    

About Erasmus Medical Center

Erasmus MC is one of the leading research institutes, nationally as well as internationally. Research activities vary from fundamental biomedical research to clinical research and from epidemiology to social healthcare and healthcare policy and management. As the largest university medical center in the Netherlands, with 2,500 students, 1,500 scientific staff and more than 12,000 employees, Erasmus MC provides referral care and last resort referral care to 3 million people in the south west of the Netherlands. Please visit www.erasmusmc.nl.

About InforSense

InforSense Ltd., the leader in agile, predictive, and visual embedded enterprise analytics, enables organizations to orchestrate and optimize their business-critical decision-making processes. Leading pharmaceutical and biotechnology, consumer goods, healthcare, financial services, manufacturing and communications companies are using the company's flagship product, InforSense, to enhance productivity by embedding analytics within their business processes. The company is privately held, with European headquarters in London, UK and North American headquarters in Cambridge, Massachusetts.

For more information visit www.inforsense.com.

InforSense and the InforSense logo are registered trademarks of InforSense Limited. All rights reserved. All other trademarks mentioned in this document are the property of their respective owners.

Contact Information

  • Contact:
    Lisa Allocca
    Red Javelin Communications, Inc.
    978-470-2227
    Email Contact